{
    "Trade/Device Name(s)": [
        "Ferrara Blood Glucose Monitoring System",
        "Ferrara Blood Glucose Test Strips",
        "Ferrara Control Solution"
    ],
    "Submitter Information": "Arkray USA",
    "510(k) Number": "K063068",
    "Predicate Device Reference 510(k) Number(s)": [],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "CGA",
        "NBW"
    ],
    "Summary Letter Date": "December 20, 2006",
    "Summary Letter Received Date": "October 6, 2006",
    "Submission Date": "October 3, 2006",
    "Regulation Number(s)": [
        "21 CFR 862.1345"
    ],
    "Regulation Name(s)": [
        "Glucose test system"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Glucose"
    ],
    "Specimen Type(s)": [
        "Fresh capillary whole blood"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "Ferrara Blood Glucose Meter"
    ],
    "Method(s)/Technology(ies)": [],
    "Methodologies": [],
    "Submission Type(s)": [
        "Analyzer",
        "Test Strip",
        "Control Solution"
    ],
    "Document Summary": "FDA 510(k) summary for Ferrara Blood Glucose Monitoring System including meter, test strips, and control solution for quantitative measurement of glucose in capillary whole blood",
    "Indications for Use Summary": "Intended for quantitative measurement of glucose in fresh capillary whole blood from fingertips or palm, for home (OTC) use by diabetics or in clinical settings as an aid to monitor diabetes control",
    "fda_folder": "Clinical Chemistry"
}